Publications

Azithromycin susceptibility in Neisseria gonorrhoeae and seasonal macrolide use.

Author(s): Olesen SW, Torrone EA, Papp JR, Kirkcaldy RD, Lipsitch M, Grad YH|Journal: J Infect Dis|PMID: 30239814| September 2018

Rising azithromycin nonsusceptibility among Neisseria gonorrhoeae threatens current treatment recommendations, but the cause of this rise is not well understood.…

Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013.

Author(s): Grad YH, Harris SR, Kirkcaldy RD, Green AG, Marks DS, Bentley SD, Trees D, Lipsitch M|Journal: J Infect Dis|PMID: 27638945| November 2016

Treatment of Neisseria gonorrhoeae infection is empirical and based on population-wide susceptibilities. Increasing antimicrobial resistance underscores the potential importance of…

Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.

Author(s): Grad YH, Kirkcaldy RD, Trees D, Dordel J, Harris SR, Goldstein E, Weinstock H, Parkhill J, Hanage WP, Bentley S, Lipsitch M|Journal: Lancet Infect Dis|PMID: 24462211| March 2014

The emergence of Neisseria gonorrhoeae with decreased susceptibility to extended spectrum cephalosporins raises the prospect of untreatable gonorrhoea. In the…

Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States.

Author(s): Goldstein E, Kirkcaldy RD, Reshef D, Berman S, Weinstock H, Sabeti P, Del Rio C, Hall G, Hook EW, Lipsitch M|Journal: Emerg Infect Dis|PMID: 22840274| August 2012

Using data from the Gonococcal Isolate Surveillance Project, we studied changes in ciprofloxacin resistance in Neisseria gonorrhoeae isolates in the…